Clinical validation of a point of care whole blood high sensitive cardiac troponin I assay: a prospective real time study on 3306 consecutive presentations with suspected acute coronary syndrome
Event: ESC Congress 2025
Topic: Biomarkers
Session: Novel biomarkers in acute and chronic coronary syndromes
The incremental value of non-necrosis biomarkers to risk stratification in acute chest pain, with MI excluded: the first prospective long term cohort study in the high sensitive troponin era
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Risk stratification and treatment options in chronic coronary syndrome
